GOSS — Gossamer Bio, Inc.

GOSSGossamer Bio, Inc.

NAS · US · Healthcare · Biotechnology · gossamerbio.com

0.2188USD+4.19%Mkt Cap: 51.87M USDP/E: —Last update: 2026-05-26

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap51.87M USD

Enterprise Value150.87M USD

Revenue (TTM)55.54M USD

Gross Profit55.54M USD

Net Income (TTM)-170.37M USD

Revenue/Share0.2410 USD

Last Price0.2188 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees161

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS38341P1021

Valuation

P/E (Trailing)—

P/E (Forward)-1.77

PEG—

EV/EBITDA-0.88

EV/Revenue2.72

P/S0.85

P/B-0.29

EPS (TTM)-0.79

EPS (Forward)-0.11

52W Range

0.16302% of range3.870

52W High3.870 USD

52W Low0.1630 USD

Profitability

Gross Margin100.00%

Oper. Margin-264.62%

EBITDA Margin0.00%

Profit Margin-351.49%

ROE138.78%

ROA-98.91%

Growth

Revenue Growth71.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-171.27M USD

CapEx (TTM)79.00K USD

FCF Margin-175.11%

FCF Yield-187.50%

Net Debt103.72M USD

Net Debt/EBITDA-0.61

Balance Sheet

Debt/Equity-1.65

Current Ratio2.20

Quick Ratio1.92

Book Value/Sh-0.6880 USD

Cash/Share0.4230 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.7 (Hold)

Target (Mean)4.456 USD

Target Range0.2800 USD – 15.00 USD

# Analysts5

Ownership

Shares Out.234.70M

Float227.15M

Insiders3.53%

Institutions72.68%

Short Interest

Short Ratio5.9d

Short % Float18.25%

Short % Out.17.05%

Shares Short40.02M

Short (prev mo.)37.50M

Technical

SMA 500.3645 (-40.0%)

SMA 2001.952 (-88.8%)

Beta2.15

S&P 52W Chg28.31%

Avg Vol (30d)9.12M

Avg Vol (10d)15.68M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—